BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19318798)

  • 1. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas.
    Kaddu S; Leinweber B
    Am J Dermatopathol; 2009 Apr; 31(2):137-9. PubMed ID: 19318798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
    Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
    Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular neurothekeoma: detailed characterization in a series of 133 cases.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Mar; 31(3):329-40. PubMed ID: 17325474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrohistiocytic skin tumors].
    Hügel H
    J Dtsch Dermatol Ges; 2006 Jul; 4(7):544-55. PubMed ID: 16827912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
    Yu H; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An infiltrative variant of non-neural granular cell tumor: a case report.
    Yeh I; Tran DT; Davis TL; Argenyi ZB
    J Cutan Pathol; 2009 Oct; 36 Suppl 1():46-51. PubMed ID: 19187104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
    Gomaa AH; Yaar M; Bhawan J
    Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin as a marker for mesothelioma.
    Kimura N; Kimura I
    Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic findings of myxoid neurothekeoma: case report based on fine-needle aspiration cytology, immunohistochemistry, and correlating histopathology.
    Levin KA; Hayden R; Hanau CA; Galindo LM
    Diagn Cytopathol; 2002 Sep; 27(3):173-6. PubMed ID: 12203866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular neurothekeoma with a plexiform morphology: a case report with a discussion of the plexiform lesions of the skin.
    Alkhalidi H; Ghazarian D
    J Cutan Pathol; 2007 Mar; 34(3):264-9. PubMed ID: 17302611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular neurothekeoma with histiocytic differentiation.
    Misago N; Satoh T; Narisawa Y
    J Cutan Pathol; 2004 Sep; 31(8):568-72. PubMed ID: 15268715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent positive staining with NKI/C3 in normal and neoplastic tissues limits its usefulness in the diagnosis of cellular neurothekeoma.
    Sachdev R; Sundram UN
    Am J Clin Pathol; 2006 Oct; 126(4):554-63. PubMed ID: 16938667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
    Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of podoplanin in tumor progression and metastasis.
    Raica M; Cimpean AM; Ribatti D
    Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.